Avalon’s New Challenges, Opportunities in Life Science Investing

March 24, 2026

LA JOLLA – As Avalon BioVentures wraps up deploying its very first fund, the $135 million ABV1, the early stage focused venture capital firm is already lookin

Search

RECENT PRESS RELEASES

Intel CEO Lip-Bu Tan: Startup investment is critical for business

SWI Editorial Staff2026-03-26T02:05:32-07:00March 26, 2026|

Amazon tests Prime shipping on the web without an Amazon login

SWI Editorial Staff2026-03-26T02:00:04-07:00March 26, 2026|

Nebius CEO Arkady Volozh explains why his blockbuster Meta deal isn’t the endgame

SWI Editorial Staff2026-03-26T02:00:02-07:00March 26, 2026|

As political winds shift, this Louisiana renewable energy venture shoots for the stars

SWI Editorial Staff2026-03-26T02:00:00-07:00March 26, 2026|

Subbyx plots Sweden launch with €30m Series A

SWI Editorial Staff2026-03-26T02:00:00-07:00March 26, 2026|

Private debt steps in as banks, VCs retreat from startups

SWI Editorial Staff2026-03-26T01:58:51-07:00March 26, 2026|